BORA overexpression promotes epithelial–mesenchymal transition and metastasis in ovarian cancer: Unveiling a novel therapeutic target for advanced disease
Year: 2025
Type: article
Abstract: This work was supported in part by grants from Instituto de Salud Carlos III (PI15/00238) to Anna Santamaria. This work was funded by the Instituto de Salud Carlos III through the projects (PI23/01144), (ICI21000/76), (FORT23/00034) (Co-funded by the European Regional Development Fund/European Social Fund; “A way to make Europe”/“Investing in your future”) to Miguel F. Segura. Marta Barber was supported by predoctoral fellowship from AGAUR (2020 FI_B 00058). This work was funded by Ministerio de Ciencia e Innovación (#PID2022-137332OB-I00) and ajuts d'Indústria del Coneixement (2021 PROD 00059) to Nora Ventosa.
DOI: 10.1002/ctm2.70285
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,470
Awards: G1102533530, TÍTULO: Ensayo fase I de ABTL0812 en niños con neuroblastoma en recaída o refractario y tumores sólidos extra-craneales, La explotación de vulnerabilidades epigenéticas como opción terapéutica en el neuroblastoma metastásico, G7139717842, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas
OpenAlex ID: W4408957337
